ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q1SCImago #5,248Hybrid

Canadian Journal of Diabetes

Acronym:cjd
•
Abbreviation (ISO):Can. J. Diabetes
•
Identifier (ISSN):1499-2671(Print)/2352-3840(Online)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
2.7↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Canadian Journal of Diabetes

WoS Q3
13462.1920182.8920193.0620204.1920212.7720222.520232.320242.620252.72026
Annual Impact Factor Metric
Current (2026):2.7
Scopus SJR & RankScopus Q1
0.956
#5,248

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
63

63 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate8.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
108articles/year
19.61% Gold OA•86.02% Original Research

Aims & Scope

The Canadian Journal of Diabetes is Canada's only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes health-care professionals. Published bimonthly, the Canadian Journal of Diabetes contains original articles; reviews; case reports; shorter articles such as Perspectives in Practice, Practical Diabetes and Innovations in Diabetes Care; Diabetes Dilemmas and Letters to the Editor.

Topics Covered (Recognized by AI)
MedicineBiology79.8%Endocrinology73%Internal medicine60.7%Diabetes mellitus57.5%Pathology38%Type 2 diabetes30.2%Biotechnology23.6%Insulin23.2%Chemistry21.9%Psychology20.8%Genetics20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Q3
Rank120/198
IndexSCIE
JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Q3
Rank123/198
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.7
Articles / Year84
Total Citations7
2025
IF2.6
Articles / Year282
Total Citations123
2024
IF2.3
Articles / Year234
Total Citations289
2023
IF2.5
Articles / Year498
Total Citations574
2022
IF2.774
Articles / Year242
Total Citations1,041

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,248Scopus Q1SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
0.956

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.40

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,257 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations704
3-Year Documents288
Citable Documents265

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate67.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
EndocrinologyQ2
Endocrinology, Diabetes and MetabolismQ2
Internal MedicineQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 8.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Canadian Journal of Diabetes (acronym: cjd, abbr: Can. J. Diabetes, ISSN: 1499-2671) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by Elsevier Inc. in Canada since 2002. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.956 (Q1), an H-index of 63.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 108 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,257 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Quarterly
Founding Year
2002
Indexing & Databases
SCIEScopusPubMed
Editorial Address
CANADIAN DIABETES ASSOC, 1400-522 UNIVERSITY AVE, TORONTO, CANADA, ONTARIO, M5G 2R5

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: db880135-2168-49b6-ad6a-57904390f4f5
Database Updated: 2026-10-16